SK Bioscience (Korea) Today
| 302440 Stock | 49,950 2,100 4.39% |
Performance0 of 100
| Odds Of DistressLess than 9
|
SK Bioscience is trading at 49950.00 as of the 26th of November 2024, a 4.39 percent increase since the beginning of the trading day. The stock's open price was 47850.0. SK Bioscience has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for SK Bioscience Co are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 7th of December 2022 and ending today, the 26th of November 2024. Click here to learn more.
Moving together with 302440 Stock
Moving against 302440 Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
302440 Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. SK Bioscience's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding SK Bioscience or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
SK Bioscience Co (302440) is traded on Korea Stock Exchange in Korea and employs 6 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 5.56 T. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate SK Bioscience's market, we take the total number of its shares issued and multiply it by SK Bioscience's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. SK Bioscience operates under Healthcare sector and is part of Biotechnology industry. The entity has 76.78 M outstanding shares.
SK Bioscience generates positive cash flow from operations, but has no cash available
Check SK Bioscience Probability Of Bankruptcy
Ownership AllocationSK Bioscience secures a total of 76.78 Million outstanding shares. SK Bioscience owns majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 69.27 % of SK Bioscience Co outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company retains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check 302440 Ownership Details
SK Bioscience Risk Profiles
Although SK Bioscience's alpha and beta are two of the key measurements used to evaluate SK Bioscience's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.82 | |||
| Standard Deviation | 2.43 | |||
| Variance | 5.93 | |||
| Risk Adjusted Performance | (0.08) |
302440 Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in SK Bioscience without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sync Your Broker Now
Sync Your BrokerSync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
| All Next | Launch Module |
SK Bioscience Corporate Management
Elected by the shareholders, the SK Bioscience's board of directors comprises two types of representatives: SK Bioscience inside directors who are chosen from within the company, and outside directors, selected externally and held independent of 302440. The board's role is to monitor SK Bioscience's management team and ensure that shareholders' interests are well served. SK Bioscience's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, SK Bioscience's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Hoon Kim | CTO Director | Profile | |
| Jinyong Park | Head Unit | Profile | |
| SookMi Hwang | Head Affairs | Profile | |
| Harry Kleanthous | Ex Innovation | Profile | |
| Sally Choe | Head Affairs | Profile | |
| JaeYong Ahn | Pres CEO | Profile |
Other Information on Investing in 302440 Stock
SK Bioscience financial ratios help investors to determine whether 302440 Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 302440 with respect to the benefits of owning SK Bioscience security.